Skip to main content
Annals of Intensive Care

Table 2 Odds ratio (95% CI) for acute kidney injury in intensive care unit hospitalization in Korea, 2008 to 2015

From: Changes in acute kidney injury epidemiology in critically ill patients: a population-based cohort study in Korea

 

Crude odds ratio (95% CI)

p valuea

Adjusted odds ratio (95% CI)

p valuea

Age (continuous)

1.02 (1.02–1.02)

< .001

1.01 (1.01–1.01)

< .001

Gender, male

1.09 (1.08–1.10)

< .001

1.02 (1.02–1.03)

< .001

Tertiary hospital

0.94 (0.91–0.97)

< .001

1.05 (1.05–1.06)

0.365

Year

1.02 (1.02–1.02)

< .001

1.18 (1.17–1.20)

< .001

Charlson index

1.08 (1.08–1.09)

< .001

0.98 (0.95–1.02)

< .001

Comorbidity

 Myocardial infarction

1.00 (0.97–1.02)

0.857

0.85 (0.83–0.87)

< .001

 Congestive heart failure

1.50 (1.48–1.53)

< .001

1.16 (1.14–1.18)

< .001

 Peripheral vascular disease

1.12 (1.15–1.18)

< .001

0.94 (0.93–0.96)

< .001

 Cerebrovascular disease

0.97 (0.95–0.98)

< .001

0.78 (0.77–0.79)

< .001

 Rheumatologic disease

1.23 (1.20–1.26)

< .001

0.98 (0.96–1.01)

0.239

 Peptic ulcer disease

1.07 (1.06–1.08)

< .001

0.88 (0.87–0.89)

< .001

 Liver disease

1.28 (1.27–1.30)

< .001

0.99 (0.98–1.01)

0.431

 Diabetes mellitus

1.61 (1.60–1.63)

< .001

1.26 (1.25–1.28)

< .001

 Renal disease

4.23 (4.15–4.32)

< .001

3.45 (3.37–3.52)

< .001

 Cancer

1.06 (1.05–1.08)

< .001

0.72 (0.70–0.74)

< .001

 AIDS/HIV

1.46 (1.18–1.81)

< .001

0.85 (0.67–1.06)

0.151

Organ dysfunction

 Respiratory

4.84 (4.75–4.94)

< .001

2.97 (2.91–3.04)

< .001

 Cardiovascular

5.89 (5.81–5.97)

< .001

4.24 (4.18–4.31)

< .001

 Hepatic

4.56 (4.33–4.81)

< .001

3.46 (3.26–3.67)

< .001

 Hematologic

5.24 (5.15–5.33)

< .001

3.64 (3.57–3.70)

< .001

 Neurologic

2.49 (2.42–2.56)

< .001

1.84 (1.78–1.90)

< .001

  1. Adjusted for age, gender, tertiary hospital, year, Charlson index, myocardial infarction, congestive heart failure, cerebrovascular disease, rheumatologic disease, peptic ulcer disease, liver disease, diabetes, renal disease, cancer, AIDS/HIV, and organ dysfunction (respiratory, cardiovascular, hepatic, hematologic, neurologic)
  2. AIDS acquired immune deficiency syndrome, CI confidence interval, HIV human immunodeficiency virus
  3. aMixed effects logistic regression model
Back to article page